Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu and Juan Li
DOI: https://doi.org/10.7861/clinmed.2020-0348
Clin Med January 2021 Pan Luo
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
Jian-ling Zheng
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
Yi Liu
BTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: associate chief pharmacist
Lin Qiu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Xiu-lan Liu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Hui-ying Xue
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Dong Liu
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist
Juan Li
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist
Article Tools
Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu, Juan Li
Clinical Medicine Jan 2021, 21 (1) e80-e83; DOI: 10.7861/clinmed.2020-0348
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.